Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2021

Jan 27, 2021

3091_iss_2021-01-27_605ce471-622c-4a27-8ec2-84909e34ce9f.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Handelsbanken Fonder AB

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares 3,400,617
Voting rights 3,400,617
Transaction
Reason for major shareholding notification Sell
Date 26/01/2021
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 3,363,986
Directly held voting rights 3,363,986
Indirectly held voting rights 0
Percentage
Directly held shares 4.95 %
Directly held voting rights 4.95 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.95 % 3,363,986
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.95 % 3,363,986
Group
total
holdings
Voting rights
3,363,986
Percentage of voting rights 4.95
Published
27/01/2021 14:15
Contact
Name
Fredrik Alheden
Phone
087013503
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25